日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial

卡瑞利珠单抗联合 CAPOX 方案（以卡瑞利珠单抗为基础的维持治疗）与单用 CAPOX 方案作为胃癌或胃食管交界处腺癌一线治疗的疗效比较：一项随机 3 期试验

期刊:Bmj-British Medical Journal
影响因子:42.7
doi:10.1136/bmj-2025-086115
Peng, Zhi; Zhang, Yanqiao; Xu, Huiting; Yang, Yan; Yang, Mudan; Zhang, Mingjun; Cheng, Ying; Chen, Xiaobing; Pan, Yueyin; Wang, Feng; Li, Qingshan; Xu, Nong; Liu, Likun; Gu, Kangsheng; Xiao, Juxiang; Zhang, Ruixing; Zhao, Qun; Chen, Jian; Lin, Lizhu; Chen, Yigui; Deng, Yanhong; Cai, Shirong; Bai, Bin; Wang, Yiru; Shen, Lin
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial

在中国晚期胰腺腺癌患者中，NALIRIFOX 对比吉西他滨联合白蛋白紫杉醇：一项随机、开放标签的 II 期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68409-0
Gao, Chuntao; Zhang, Yanqiao; Qu, Xiujuan; Chen, Xingyun; Zhang, Jingdong; Wu, Heshui; Sun, Meili; Zha, Yong; Wang, Junbin; Wang, Yusheng; Li, Zhihua; Gao, Jinghua; Lin, Rongbo; Zang, Aimin; Zhang, Huiqing; Yuan, Xianglin; Du, Chengyou; Zhao, Jun; Yang, Yongsheng; Shi, Xuetao; Cheng, Wei; Wang, Bangmao; Wu, Shikai; Zhao, Tiansuo; Wang, Jian; Gao, Song; Wang, Xiuchao; Ma, Weidong; Liu, Rui; Shi, Yehui; Liu, Yanping; Xie, Yijiao; Niu, Miao; Zhao, Fuchen; Yu, Jun; Hao, Jihui
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Loss of Hepatocyte FOXA3 Improves MASH and Atherosclerosis in Hyperlipidemic Ldlr-Deficient Mice.

肝细胞 FOXA3 的缺失可改善高脂血症 Ldlr 缺陷小鼠的 MASH 和动脉粥样硬化。

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms27031468
Wang Hui, Hu Shuwei, Wang Jiayou, Gopoju Raja, Lin Li, Gunawardana Lakshitha, Wang Xinwen, Yin Liya, Zhang Yanqiao
动脉粥样硬化
细胞生物学
Mas
LDLR
发表日期：2026
文献求助 收藏

Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study

HAIC联合PD-(L)1抑制剂和贝伐珠单抗与HAIC联合PD-(L)1抑制剂和TKI治疗晚期肝细胞癌的疗效和安全性：一项回顾性队列研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18020314
Wang, Zizhuo; Xu, Wei; Song, Songlin; Ren, Yanqiao; Liu, Jiacheng; Liu, Yiming; Kan, Xuefeng; Zheng, Chuansheng; Liang, Bin
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A Robust Immunohistochemistry-Based Classification for BRAF V600E-Mutant Colorectal Cancer With Clinical Implications.

基于免疫组织化学的BRAF V600E突变型结直肠癌的稳健分类及其临床意义。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70231
Liu Chao, Ruan Yuli, Wu Tong, Luan Xindi, Ma Yue, Wang Hong, Dang Tianjiao, Ou Yiwen, Wang Bojun, Zhang Chunhui, Meng Hongxue, Zhang Yanqiao
肠癌
免疫/内分泌
BRAF
发表日期：2026
文献求助 收藏

A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAF(V600E) Mutant Metastatic Colorectal Cancer: The NAUTICAL Study

一项针对BRAF(V600E)突变型转移性结直肠癌中国患者的随机试验：恩考拉非尼联合西妥昔单抗与伊立替康/西妥昔单抗或FOLFIRI/西妥昔单抗的比较研究：NAUTICAL研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71697
Xicheng, Wang; Yanhong, Deng; Yanqiao, Zhang; Tianshu, Liu; Xianglin, Yuan; Jianwei, Yang; Tao, Zhang; Aimin, Zang; Yu, Liu; Li, Huang; Feng, Ye; Hong, Zong; Yi, Ba; Isabelle, Klauck; Jean-Claude, Vedovato; Mélanie, Groc; Angela, Guo; Jian, Li; Lin, Shen
BRAF
肿瘤
肠癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Unraveling pyrrolizidine alkaloid-induced liver damage with an integrative spatial lipidomics framework

利用整合的空间脂质组学框架揭示吡咯里西啶生物碱诱导的肝损伤

期刊:
影响因子:
doi:10.1016/j.jpha.2025.101340
Chen, Yilin; Xu, Jie; Lam, Thomas Ka-Yam; Xie, Yanqiao; Wang, Jianing; Xiong, Aizhen; Wang, Zhengtao; Cai, Zongwei; Li, Linnan; Yang, Li
肝损伤
毒理研究
发表日期：2026
文献求助 收藏

First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial

一线舒格马利单抗联合化疗治疗晚期胃癌：GEMSTONE-303随机临床试验

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2024.28463
Zhang, Xiaotian; Wang, Jufeng; Wang, Gang; Zhang, Yanqiao; Fan, Qingxia; Lu, Chuangxin; Hu, Changlu; Sun, Meili; Wan, Yiye; Sun, Sanyuan; Wang, Junye; Zhang, Li; Shu, Yongqian; Luo, Jie; Zhu, Dan; Shen, Zhenwei; Yao, Sheng; Shi, Qingmei; Yang, Jason; Shen, Lin
胃癌
肿瘤
肿瘤免疫
多发性硬化症
发表日期：2025
文献求助 收藏

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update

中国临床肿瘤学会（CSCO）：结直肠癌诊疗临床指南（2024年更新版）

期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12639
Wang, Feng; Chen, Gong; Zhang, Zhen; Yuan, Ying; Wang, Yi; Gao, Yuan-Hong; Sheng, Weiqi; Wang, Zixian; Li, Xinxiang; Yuan, Xianglin; Cai, Sanjun; Ren, Li; Liu, Yunpeng; Xu, Jianmin; Zhang, Yanqiao; Liang, Houjie; Wang, Xicheng; Zhou, Aiping; Ying, Jianming; Li, Guichao; Cai, Muyan; Ji, Gang; Li, Taiyuan; Wang, Jingyu; Hu, Hanguang; Nan, Kejun; Wang, Liuhong; Zhang, Suzhan; Li, Jin; Xu, Rui-Hua
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2-Positive Locally Advanced Resectable Gastric Cancer: A Randomized Clinical Trial

阿特珠单抗和曲妥珠单抗联合化疗治疗ERBB2阳性局部晚期可切除胃癌：一项随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2025.0522
Peng, Zhi; Zhang, Xiaotian; Liang, Han; Zheng, Zhichao; Wang, Zhenning; Liu, Hao; Hu, Jiankun; Sun, Yihong; Zhang, Yanqiao; Yan, Han; Tong, Lin; Xu, Jiahui; Ji, Jiafu; Shen, Lin
胃癌
肿瘤
ERBB2
肿瘤免疫
发表日期：2025
文献求助 收藏